 |
 |
|
|
RESÚMENES DICIEMBRE 2006 |
Addictive Disorders
(Haga un click en la información del journal para acceder al resúmen)
Treatment of cocaine dependent treatment
seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo
Levin FR, Evans SM, Brooks DJ, Garawi F
Drug Alcohol Depend. 2006 Aug 21; [Epub
ahead of print]
Concurrent cannabis use during treatment for
comorbid ADHD and cocaine dependence: effects on
outcome
Aharonovich E, Garawi F, Bisaga A, Brooks D, Raby WN, Rubin E, Nunes EV, Levin FR
Am J Drug Alcohol Abuse. 2006;32(4):629-35
The Mechanistic
Classification of Addictive Drugs
Christian Lüscher, Mark A. Ungless
PLoS Medicine | November 2006 | Volume 3 | Issue 11 | e437
Stimulant use and symptoms of
abuse/dependence: Epidemiology and associations with cannabis use—A twin study
Michael T. Lynskey, Julia D. Grant, Li Li,
Elliot C. Nelson, Kathleen K. Bucholz, Pamela A.F.
Madden, Dixie Statham, Nicholas G. Martin and Andrew C. Heath
Drug and Alcohol Dependence. Volume 86, Issues 2-3, 12 January 2007, Pages 147-153
Male–female differences in the risk of
progression from first use to dependence upon cannabis, cocaine, and alcohol
Fernando A. Wagner
and James C. Anthony
Drug and Alcohol Dependence. Volume 86, Issues 2-3, 12 January 2007, Pages 191-198
Serotonergic responsiveness in human cocaine
users
Udi E. Ghitza, Richard B. Rothman, David A. Gorelick,
Jack E. Henningfield and Michael H. Baumann
Drug and Alcohol Dependence. Volume 86, Issues 2-3, 12 January 2007, Pages 207-213
Nonmedical use of prescription drugs among
a longitudinal sample of dependent and problem drinkers
Helen Matzger and Constance Weisner
Drug and Alcohol Dependence. Volume 86, Issues 2-3, 12 January 2007, Pages 222-229
Evaluation of the use of buprenorphine
for opioid withdrawal in an emergency department
M.L. Berg, U. Idrees, R. Ding, S.A. Nesbit, H.K. Liang and M.L. McCarthy
Drug and Alcohol Dependence. Volume 86, Issues 2-3, 12 January 2007, Pages 239-244
Jason C. Ehret, Patricia S. Day, Ryan Wiegand,
Joanne Wojcieszek and R. Andrew Chambers
Drug and Alcohol Dependence. Volume 86, Issues 2-3, 12 January 2007, Pages 283-286
New lower nicotine cigarettes can produce
compensatory smoking and increased carbon monoxide exposure
Andrew A. Strasser, Caryn Lerman, Paul M. Sanborn, Wallace B. Pickworth
and Eric A. Feldman
Drug and Alcohol Dependence. Volume 86, Issues 2-3, 12 January 2007, Pages 294-300
An endocannabinoid
mechanism in relapse to drug seeking: A review of animal studies and clinical
perspectives
Liana Fattore, M. Sabrina Spano, Serena Deiana, Valeria Melis, Gregorio
Cossu, Paola Fadda and Walter Fratta
Brain Research Reviews. Volume 53, Issue 1, January 2007, Pages
1-16
Nicotine and cannabinoids:
Parallels, contrasts and interactions
Maria-Paz Viveros, Eva M. Marco and Sandra E. File
Neuroscience & Biobehavioral
Reviews. Volume 30, Issue 8, 2006,
Pages 1161-1181
Exacerbation of
Psychiatric Symptoms During Substance Use Disorder
Treatment
Mark A. Ilgen and Rudolf H. Moos
Psychiatr Serv 57:1758-1764, December 2006
Buprenorphine Reduces Alcohol Drinking Through
Activation of the Nociceptin/Orphanin FQ-NOP Receptor
System
Roberto Ciccocioppo, Daina Economidou, Roberto Rimondini,
Wolfgang Sommer, Maurizio Massi
and Markus Heilig
Biological Psychiatry. Volume 61, Issue 1, 1 January 2007, Pages 4-12
Metabotropic Glutamate Receptor Antagonists:
Novel Therapeutics for Nicotine Dependence and Depression?
Athina Markou
Biological Psychiatry. Volume 61, Issue 1, 1 January 2007, Pages 17-22
Buprenorphine Duration of Action: Mu-opioid
Receptor Availability and Pharmacokinetic and Behavioral Indices
Mark Greenwald,
Chris-Ellyn Johanson, Joshua Bueller,
Yan Chang, David E. Moody, Michael Kilbourn, Robert Koeppe and Jon-Kar Zubieta
Biological Psychiatry. Volume 61, Issue 1, 1 January 2007, Pages 101-110
Catechol-O-Methyltransferase (COMT) Gene Variants Predict
Response to Bupropion Therapy for Tobacco Dependence
Wade H. Berrettini, E. Paul Wileyto,
Leonard Epstein, Stephanie Restine, Larry Hawk, Peter
Shields, Ray Niaura and Caryn
Lerman
Biological Psychiatry. Volume 61, Issue 1, 1 January 2007, Pages 111-118
Quetiapine in relapse prevention
in alcoholics suffering from craving and affective symptoms:
a case series
B. Croissant, O. Klein, L. Gehrlein, A. Kniest, D.
Hermann, A. Diehl and K. Mann
European Psychiatry. Volume 21, Issue 8, December 2006, Pages 570-573
Modafinil
enhances extracellular levels of dopamine in the
nucleus accumbens and increases wakefulness in rats
Eric Murillo-Rodríguez,
Reyes Haro, Marcela Palomero-Rivero,
Diana Millán-Aldaco and René Drucker-Colín
Behavioural Brain
Research.
Volume 176, Issue 2, 25 January 2007,
Pages 353-357
MDMA (Ecstasy) and human dopamine, norepinephrine,
and serotonin transporters: implications for MDMA-induced neurotoxicity
and treatment
Christopher D. Verrico,
Gregory M. Miller and Bertha K. Madras
Psychopharmacology. Volume 189, Number 4 / January, 2007: 489-503
Neuropsychological function in ecstasy users: a study controlling for polydrug use
Jonathan P. Roiser, Robert D. Rogers and
Barbara J. Sahakian
Psychopharmacology. Volume 189, Number 4 / January, 2007: 505-516
Elevated impulsivity and impaired decision-making cognition in heavy
users of MDMA (“Ecstasy”)
Boris B. Quednow, Kai-Uwe Kühn, Christian Hoppe, Jens Westheide,
Wolfgang Maier, Irene Daum and
Michael Wagner
Psychopharmacology. Volume 189, Number 4 / January, 2007: 517-530
The effects of fluoxetine on the subjective
and physiological effects of 3,4-methylenedioxymethamphetamine
(MDMA) in humans
Manuel Tancer and Chris-Ellyn Johanson
Psychopharmacology. Volume 189, Number 4 / January, 2007: 565-573
Treatment of alcohol withdrawal syndrome with a
combination of tiapride/carbamazepina. Results of a pooled analysis in 540 patients
Michael Soyka, Peggy Schmidt, Michael Franz,
Thomas Barth, Michael de Groot, Thorsten Kienast,
Thomas Reinert, Christoph Richter
and Greif Sander
Origin of the Comorbidity
of Anxiety Disorders and Alcohol Dependence: Findings of a General Population
Study
Loes A. Marquenie,
Annemiek Schadé, Anton
J.L.M. van Balkom, Hannie
C. Comijs, Ron de Graaf,
Wilma Vollebergh, Richard van Dyck,
Wim van den Brink
European
Addiction Research 2007;13:39-49
Naltrexone-Assisted Rapid Methadone
Discontinuation: A Pilot Study
Xavier Camarasa, Yasser Khazaal, Jacques Besson, Daniele
Fabio Zullino
European
Addiction Research 2007;13:20-24
Mood disorders affect drug treatment success
of drug-dependent pregnant women
Heather E.
Fitzsimons, Michelle Tuten, Varsha
Vaidya and Hendrée E. Jones
Journal of Substance Abuse Treatment. Volume 32, Issue 1, January 2007, Pages 19-25
Manifestations of
early brain recovery associated with abstinence from alcoholism
Andreas J. Bartsch,
György Homola, Armin Biller, Stephen M. Smith, Heinz-Gerd
Weijers, Gerhard A. Wiesbeck,
Mark Jenkinson, Nicola De Stefano, László Solymosi and Martin Bendszus
A follow up study on the efficacy of metadoxine
in the treatment of alcohol dependence
Substance Abuse Treatment, Prevention, and Policy 2006, 1:35
Abstinence and
Initiation of Treatment Following Inpatient Detoxification
Richard D. Blondell,
Susan J. Smith, Marta C. Canfield, Timothy J. Servoss
American Journal on Addictions. Volume 15, Number 6 / November-December 2006: 462 - 467
Prevalence and
Impact of Alcohol Dependence
Bohn MJ, Swift RM
J Clin Psychiatry 2006;
67(Suppl.14):6-13
Tradictional
Pharmacotherapy of Alcohol Dependence
Wilkins JN
J Clin Psychiatry 2006;
67(Suppl.14):14-22
New Therapeutic
Options for Alcohol Dependence: Long-Acting Intramuscular Formulations of Naltrexone
Garbutt JC
J Clin Psychiatry 2006; 67(Suppl.14):30-34
Emerging
Pharmacologic Treatments for Alcohol Dependence
Garbutt JC